Cigna Stock News

Cigna Corporation officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, Cigna officials expect to reaffirm projected full year 2021 consolidated adjusted income from operations on a per share basis of at least $20.35 per share, and projected growth of at least 10% in consolidated The post CIGNA CORP FILES (8-K) Disclosing Regulation FD Disclosure appeared first on InsuranceNewsNet .

Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, CI, HIG, PRU, AIZ and ORI as the impact of the p

Shares of Cigna Co. (NYSE:CI) have received a consensus rating of Buy from the twenty-three analysts that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, sixteen have assigned a buy rating and one has issued a strong buy []

Courier Capital LLC lowered its position in Cigna Co. (NYSE:CI) by 7.5% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,053 shares of the health services providers stock after selling 85 shares during the period. Courier Capital LLCs holdings in Cigna were worth $211,000 as of its most recent SEC filing. A number of []

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lessened its position in shares of Cigna Co. (NYSE:CI) by 10.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,394 shares of the health services providers stock after selling 4,324 shares during the quarter. Cigna comprises about []

Private Capital Group LLC raised its position in shares of Cigna Co. (NYSE:CI) by 5.7% in the third quarter, HoldingsChannel reports. The firm owned 4,982 shares of the health services provider’s stock after buying an additional 269 shares during the quarter. Private Capital Group LLC’s holdings in Cigna were worth $997,000 as of its most […]

Cigna (NYSE:CI)s stock had its buy rating reiterated by Seaport Res Ptn in a note issued to investors on Wednesday, Zacks.com reports. Seaport Res Ptn also issued estimates for Cignas Q4 2021 earnings at $4.81 EPS, FY2021 earnings at $20.50 EPS, Q1 2022 earnings at $5.60 EPS, Q2 2022 earnings at $5.24 EPS, Q3 2022 []

Allergic Rhinitis Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while

Research analysts at Seaport Research Partners initiated coverage on shares of Cigna (NYSE:CI) in a research note issued on Wednesday, Price Targets.com reports. The firm set a buy rating and a $270.00 price target on the health services providers stock. Seaport Research Partners target price would suggest a potential upside of 24.44% from the stocks []

J.P. Morgan Stick to Their Buy Rating for Cigna Corp

Foster Victor Wealth Advisors LLC lifted its stake in Cigna Co. (NYSE:CI) by 31.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 20,106 shares of the health services providers stock after purchasing an additional 4,862 shares during the quarter. Foster Victor Wealth Advisors LLCs []

Investment analysts at Seaport Global Securities initiated coverage on shares of Cigna (NYSE:CI) in a research note issued on Wednesday, The Fly reports. The firm set a buy rating on the health services providers stock. A number of other research analysts have also weighed in on CI. Truist dropped their price target on shares of []

Related Stocks: TSM , AMZN , NVDA , ALB , AMGN , ICE , RTX , CI , ASML , CMCSA , CHD , ARKF , LYB , PPL , TFC , O ,

Related Stocks: CI , CAH , UHS , HLF , UTHR , GLPG , MRK , RCOR , GILD , LPTX , PTGX , HRC , AMGN , AFMD , CHRS , SYNH , CHAQ.U ,

Cigna (NYSE:CI) had its price objective trimmed by Morgan Stanley from $275.00 to $255.00 in a report published on Friday morning, The Fly reports. The firm currently has an overweight rating on the health services providers stock. The analysts noted that the move was a valuation call. A number of other equities analysts have also []